Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
allof, andfor, andIntelliShuttle, asat, assumptionsin, atrial, awaiting, bio, Companyreceived, condensed, critical, deceased, don, globalising, inequivalence, inequivalent, IntellipharmaceuticsInternational, laid, ncorporated, ormost, patentc, recession, steered, Subsidy, Subtopic, toExhibit, withstanding, worst
Removed:
Allport, Andrew, ASU, AUC, AUCinf, AUCt, Aug, biochemistry, bioequivalency, bioinequivalence, bioinequivalent, blinded, catalog, challenged, Chemfet, Chinese, Cmax, College, Columbia, crossover, deem, differentiated, discovery, dosed, effecting, Eldon, exceeding, exclusively, fasted, fasting, fed, Fellowship, field, founder, Halifax, healthy, home, infinity, instrumental, interval, jointly, kind, Lyceum, Mary, MBS, meal, metric, multimedia, municipal, path, Pathology, payout, plasma, prompt, Quinton, randomized, refilled, Sanofi, screening, sector, showed, Smith, standardized, streamlining, Symphony, terminable, therefrom, thirteen, Trazodone, TRx, vacancy, warranty, Wave, William, Winthrop
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 4.69 Ex - 4.69
- 4.70 Ex -4.70
- 4.71 Ex - 4.71
- 4.72 Ex - 4.72
- 4.73 Ex - 4.73
- 4.74 Ex - 4.74
- 4.75 Ex - 4.75
- 4.76 Ex - 4.76
- 4.77 Ex - 4.77
- 4.78 Ex - 4.78
- 4.79 Ex - 4.79
- 4.80 Ex - 4.80
- 4.81 Ex - 4.81
- 4.82 Ex - 4.82
- 4.83 Ex - 4.83
- 8.1 Ex - 8.1
- 12.1 Ex - 12.1
- 12.2 Ex - 12.2
- 13.1 Ex - 13.1
- 13.2 Ex - 13.2
- 2.1 EX-2.1
- 15.1 Consent of Independent Registered Public Accounting Firm
- Download Excel data file
- View Excel data file
IPCIF similar filings
Filing view
External links